Aripiprazole in Children with Tourette's Disorder and Co-morbid Attention-Deficit/Hyperactivity Disorder: A 12-Week, Open-Label, Preliminary Study-Reference-Cited by-同舟云学术

Aripiprazole in Children with Tourette's Disorder and Co-morbid Attention-Deficit/Hyperactivity Disorder: A 12-Week, Open-Label, Preliminary Study

Published:2012-04 Issue:2 Volume:22 Page:120-125
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Masi Gabriele¹,Gagliano Antonella²,Siracusano Rosamaria²,Berloffa Stefano¹,Calarese Tiziana²,Ilardo Giovanna²,Pfanner Chiara¹,Magazù Angela¹,Cedro Clemente³

Affiliation:

1. IRCCS Stella Maris, Scientific Institute Child Neurology and Psychiatry, Calambrone, Pisa, Italy.

2. Division of Child Neurology and Psychiatry, University of Messina, Messina, Italy.

3. Department of Neurosciences, Psychiatric and Anaesthesiological Sciences, University of Messina, Messina, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2011.0081

Reference49 articles.

1. STIMULANT-ATYPICAL ANTIPSYCHOTIC INTERACTION AND ACUTE DYSTONIA

2. Meta-Analysis: Treatment of Attention-Deficit/Hyperactivity Disorder in Children With Comorbid Tic Disorders

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms;Expert Review of Neurotherapeutics;2024-07-21

2. Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder;Expert Review of Neurotherapeutics;2024-06-25

3. SOCIAL COMMUNICATION DISORDER IN AN ADOLESCENT WITH ADHD AND TOURETTE’S DISORDER TREATED WITH ARIPIPRAZOLE;PSYCHIATRIA DANUBINA;2022-04-22

4. Treatment of Psychiatric Comorbidities in Tourette Syndrome;Tourette Syndrome;2022-04

5. Atypical antipsychotics for treatment of Tourette syndrome;International Review of Movement Disorders;2022